Clinical Trials Logo

Actinic Keratosis Olsen Grade I/II clinical trials

View clinical trials related to Actinic Keratosis Olsen Grade I/II.

Filter by:
  • None
  • Page 1

NCT ID: NCT01757613 Completed - Clinical trials for Actinic Keratosis Olsen Grade I/II

Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis

Start date: December 2012
Phase: Phase 2
Study type: Interventional

In this three-armed dose-finding trial 3 AK 3012 topical formulations shall be investigated with respect to safety and efficacy in order to identify the optimal concentration in the topical formulation. The main objective of the trial is to determine the optimal concentration of the active agent in the topical formulation as quantified by the change of the number of skin alterations in pre-defined areas in a time period from inclusion in the trial until the end of treatment (3 months) or prior complete healing.